Cargando…
Immunomodulatory effects of soluble CD5 on experimental tumor models
Modulation of antitumor immune responses by targeting immune checkpoint regulators has been proven successful in the treatment of many different tumors. Recent evidence shows that the lymphocyte receptor CD5 –a negative regulator of TCR-mediated signaling- may play a role in the anti-tumor immune re...
Autores principales: | Simões, Inês T., Aranda, Fernando, Carreras, Esther, Andrés, Maria Velasco-de, Casadó-Llombart, Sergi, Martinez, Vanesa G., Lozano, Francisco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746133/ https://www.ncbi.nlm.nih.gov/pubmed/29296231 http://dx.doi.org/10.18632/oncotarget.22564 |
Ejemplares similares
-
Multifaceted effects of soluble human CD6 in experimental cancer models
por: Simões, Inês T, et al.
Publicado: (2020) -
Soluble CD5 and CD6: Lymphocytic Class I Scavenger Receptors as Immunotherapeutic Agents
por: Velasco-de Andrés, María, et al.
Publicado: (2020) -
Contribution of Evolutionary Selected Immune Gene Polymorphism to Immune-Related Disorders: The Case of Lymphocyte Scavenger Receptors CD5 and CD6
por: Casadó-Llombart, Sergi, et al.
Publicado: (2021) -
Gene variation impact on prostate cancer progression: Lymphocyte modulator, activation, and cell adhesion gene variant contribution
por: Casadó‐Llombart, Sergi, et al.
Publicado: (2022) -
Conserved Bacterial-Binding Peptides of the Scavenger-Like Human Lymphocyte Receptor CD6 Protect From Mouse Experimental Sepsis
por: Martínez-Florensa, Mario, et al.
Publicado: (2018)